Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification

References 

1. Petinaki E, Kontos F, Pratti A, Skulakis C, Maniatis AN. Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece. Int J Antimicrob Agents. 2003;21:67–70
   • Abstract
   • Full Text
   • Full-Text PDF (141 KB)
   • CrossRef
2. Silva-Costa C, Ramirez M, Melo-Cristino J. Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal. Clin Microbiol Infect. 2006;12:513–518
   • MEDLINE
3. Amezaga MR, McKenzie H. Molecular epidemiology of macrolide resistance in β-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother. 2006;57:443–449
   • MEDLINE
   • CrossRef
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; approved standard. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
5. Blackman Northwood J, Del Grosso M, Cossins LR, Coley MD, Creti R, Pantosti A, et al. Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005. Antimicrob Agents Chemother. 2009;53:1921–1925
   • CrossRef
6. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun. 2001;69:2416–2427
   • MEDLINE
   • CrossRef
7. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996;34:953–958
   • MEDLINE